| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
Figure 2. (a) Tumour control probability (TCP) as a function of the fraction of tumour hypoxia (fh) for individual patients of prostate cancer. The prescription dose is 145 Gy for 125I brachytherapy. (b) Dose escalation of 125I brachytherapy required overcoming tumour hypoxia (to achieve a TCP of 81%) as a function of hypoxia fraction fh.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |